Nutcracker Therapeutics

EMERYVILLE, CA · Founded 2017 · CIK 0001741042 · Biotech

nutcrackerx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$172M
4 Form D · Sep 2021
61 months since last filing
Contracts
—
No federal contracts on record
Patents
40
19 granted · 21 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$4,000,000
Private capital raisedForm D · SEC$9,998,198
Private capital raisedForm D · SEC$13,999,990
Private capital raisedForm D · SEC$144,499,977
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2867VIVOSPHERE LLC——
2868BETASTEM THERAPUETICS, INC.——
2869NUTRIWYO, LLC——
2870Nutcracker Therapeutics—$172M
2871REDVAULT BIOSCIENCES LP——
2872Vertex Pharmaceuticals——
2873Q-State Biosciences, Inc.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • Madhavan BalachandranExecutive Officer
  • Samuel DeutschExecutive Officer
  • Benjamin EldridgeExecutive Officer
  • Igor KhandrosDirector · Executive Officer
  • Robert NelsenDirector
  • James ZhuExecutive Officer

Patents

USPTO · 19 granted of 40

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.